Obesity

Medifast Program Combined with Appetite Suppressants Proven to Yield Double the Weight Loss Compared to Suppressants Alone

Published in Obesity and Diabetes Week, August 11th, 2008

Medifast, Inc. (NYSE:MED) announced that a recent study published in 'The Journal of Eating and Weight Disorders' shows that individuals taking appetite suppressant medications can expect double the weight loss when they combine their drug therapy with a medical protocol using Medifast Meal Replacement Supplements.

The 52-week study, conducted by researchers at the University of Missouri-Kansas City School of Medicine and Baylor College of Medicine shows that participants who consistently used Medifast Meal Replacements along with pharmacotherapy lost an average of 14% of their body weight in one year. This amount of weight loss is approximately double what is seen in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2008-08-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry